Archive · 4 Sep 2025
India's Health Ministry Amends Drug Trial Rules for Faster Approvals
The Indian government is changing the rules for testing new medicines to make it faster for companies.
Companies can now tell the government they're starting certain tests instead of waiting for approval.
Approvals will be quicker.
This helps the pharmaceutical industry grow and brings more research to India.
Specifically, the changes allow faster initiation of studies for drugs already approved in major markets.
This aims to make India a global hub for drug development and clinical trials.
Health Ministry is amending drug trial rules.
Companies can notify authorities before certain tests, bypassing approvals.
Application processing time will be reduced from 90 to 45 days.
Faster initiation of studies on drugs already approved in major markets.
The changes aim to attract global drug developers and boost the pharma sector.
- Who
- Union Health Ministry
- What
- Amending drug trial rules
- When
- Notification issued September 3
- Where
- India
- Why
- Promote growth of the Indian pharma industry
- Regulatory Change
- Amendments to New Drugs and Clinical Trials Rules, 2019
- Objective
- Expedite drug development and approval timelines
- Key Change
- Notification-based system for certain trials
- Licensing Time Reduction
- 90 to 45 days for test license applications
- Scope of Change
- Applies to oral formulations approved in stringent regulatory countries
Sources
Pharma Research To Get Boost As Government Eases Licence Norms
Health ministry to amend New Drugs & Clinical Trials Rules to promote ease of doing business
Govt plans easing of clinical trial rules to attract global pharma, faster approvals likely
Centre Proposes Faster Drug Trial Approvals With Rule Changes
Health Ministry proposes key amendments to ease drug trials rules
Government moves to trim red tape around drug research
Health Ministry to ease test licence, BA/BE study rules; pharma sector set to gain
India set to halve time for drug trial nod, endorse major overseas approvals
